157 related articles for article (PubMed ID: 19262146)
1. Phosphorylation of merlin regulates its stability and tumor suppressive activity.
Ye K
Cell Adh Migr; 2007; 1(4):196-8. PubMed ID: 19262146
[TBL] [Abstract][Full Text] [Related]
2. Akt phosphorylation of merlin enhances its binding to phosphatidylinositols and inhibits the tumor-suppressive activities of merlin.
Okada M; Wang Y; Jang SW; Tang X; Neri LM; Ye K
Cancer Res; 2009 May; 69(9):4043-51. PubMed ID: 19351837
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.
Rong R; Tang X; Gutmann DH; Ye K
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747
[TBL] [Abstract][Full Text] [Related]
4. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
Tang X; Jang SW; Wang X; Liu Z; Bahr SM; Sun SY; Brat D; Gutmann DH; Ye K
Nat Cell Biol; 2007 Oct; 9(10):1199-207. PubMed ID: 17891137
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.
Alfthan K; Heiska L; Grönholm M; Renkema GH; Carpén O
J Biol Chem; 2004 Apr; 279(18):18559-66. PubMed ID: 14981079
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.
Thaxton C; Lopera J; Bott M; Fernandez-Valle C
Oncogene; 2008 Apr; 27(19):2705-15. PubMed ID: 17998937
[TBL] [Abstract][Full Text] [Related]
7. Merlin sumoylation is required for its tumor suppressor activity.
Qi Q; Liu X; Brat DJ; Ye K
Oncogene; 2014 Oct; 33(41):4893-903. PubMed ID: 24166499
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Laulajainen M; Muranen T; Carpén O; Grönholm M
Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
Horiguchi A; Zheng R; Shen R; Nanus DM
Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
[TBL] [Abstract][Full Text] [Related]
10. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
Huang J; Chen J
Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
[TBL] [Abstract][Full Text] [Related]
11. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
[TBL] [Abstract][Full Text] [Related]
12. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
[TBL] [Abstract][Full Text] [Related]
13. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
[TBL] [Abstract][Full Text] [Related]
14. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M
Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658
[TBL] [Abstract][Full Text] [Related]
15. The merlin interacting proteins reveal multiple targets for NF2 therapy.
Scoles DR
Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinase links Rac/Cdc42 signaling to merlin.
Xiao GH; Beeser A; Chernoff J; Testa JR
J Biol Chem; 2002 Jan; 277(2):883-6. PubMed ID: 11719502
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q
Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
Muranen T; Grönholm M; Renkema GH; Carpén O
Oncogene; 2005 Feb; 24(7):1150-8. PubMed ID: 15580288
[TBL] [Abstract][Full Text] [Related]
20. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]